The GLOW Program: GLP-1 and Lifestyle for Wellness
Official title: The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness
Run by University of Texas at Austin · NCT07760896 · Data updated 2026-11-12
This study tests whether a 30-day WILD 5 Wellness lifestyle program can improve physical and emotional well-being in adults already taking a GLP-1 or GLP-1/GIP medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (The Colony, Texas) |
| Status | Recruiting |
| Started | September 15, 2026 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT07760896 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older currently prescribed a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist for an FDA-approved indication and with reliable internet access.
✕Probably not a fit
Participants not experiencing mood, sleep, or wellness improvements from lifestyle interventions may not notice a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults on a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist for an FDA-approved use and adds a 30-day structured wellness program focused on exercise, mindfulness, sleep, social connection, and nutrition. Participants complete online surveys before and after the program and log daily tracking during the 30 days. The trial does not modify participants' medications; it assesses changes in mood, anxiety, functioning, mindfulness, self-compassion, eating behaviors, pain, and overall wellness as a result of the wellness program.
Why it matters
Potential benefit: If successful, participants may experience improvements in mood, stress management, sleep, and overall well-being while continuing their GLP-1–based therapy.
How similar studies have gone: Other studies using structured lifestyle programs alongside metabolic therapies have shown potential benefits for well-being, but this exact approach with GLP-1–treated adults is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age 18 years or older. Able to speak, read, and understand English. Interested in supporting physical and emotional well-being. Access to a reliable Internet-enabled device, such as a computer, smartphone, or tablet. Possess basic skills needed to complete online study forms. Currently prescribed and taking a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist by a licensed healthcare practitioner. Report that the medication was prescribed for an FDA-approved indication, such as type 2 diabetes mellitus, chronic weight management for obesity or overweight with at least one weight-related condition, moderate-to-severe obstructive sleep apnea in adults with obesity, or another FDA-approved cardiometabolic indication. Willing to complete online consent, registration, program measures, and daily tracking forms. Willing to participate in the 30-day WILD 5 Wellness program delivered as part of the GLOW Study. \- Exclusion Criteria: Under 18 years of age. Unable to speak, read, or understand English. Do not have access to a reliable Internet-enabled device. Do not possess basic skills needed to complete online study forms. Not currently prescribed and taking a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist by a licensed healthcare practitioner. Report that the medication was not prescribed for an FDA-approved indication. Pregnant or planning to become pregnant in the next 30 days. Currently have thoughts about harming themselves or someone else. Currently experiencing symptoms suggestive of active psychosis. Unwilling or unable to complete the required online study forms or participate in the 30-day \-
Where it's running
-
The GLOW Study
The Colony, Texas, United States Recruiting
Study contacts
- Principal investigator: Saundra Jain, MA, PsyD, LPC — The University of Texas at Austin School of Nursing
- Study coordinator: Saundra Jain, MA, PsyD, LPC
- Email: saundrajain@gmail.com
- Phone: 888-252-7806
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting and analyzing health data from a diverse population
This study is trying to see how different foods and lifestyles affect health by collecting health samples from a diverse group of people to create personalized diet and lifestyle suggestions.
-
Examining the impact of digital wellness modules on quality of life
This study is testing if using a smartphone app with mindfulness and exercise can help healthy adults feel better and reduce stress, anxiety, and depression.
-
Non-invasive light stimulation to improve attention in adults
This study is testing if a non-invasive light treatment can help improve attention in adults, including those with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.